2.3 Cancer
New technologies and research are revolutionizing cancer screening and diagnosis by making them more precise, less invasive, and more accessible. Innovations are focused on three main areas: blood-based tests, advanced imaging, and artificial intelligence (AI).
Blood-based Cancer Screening
One of the most significant innovations is the development of “liquid biopsies,” which are blood tests that can detect cancer by analyzing circulating tumor DNA (ctDNA)—fragments of DNA shed by cancer cells into the bloodstream. They offer a non-invasive way to screen for multiple cancers at once, often at much earlier stage of disease than traditional cancer screening tests:
- Multi-Cancer Early Detection (MCED) Tests: These tests are designed to screen for a variety of cancers simultaneously from a single blood draw. They are still in development and clinical trials, but hold the promise of a future where annual cancer screening is as simple as a routine blood test.
- Minimal Residual Disease (MRD) Testing: This type of liquid biopsy is used after a patient has completed cancer treatment (like surgery or chemotherapy). It helps detect small amounts of remaining cancer cells, allowing doctors to identify patients at high risk of recurrence and adjust their treatment plan accordingly.
Advanced Imaging and Ai
Innovations in medical imaging are making cancer detection more accurate and earlier. These technologies are often combined with AI to help clinicians analyze complex data.
- AI-Enhanced Mammography: AI algorithms are now being used to analyze mammograms. They can identify subtle patterns and potential tumors that might be missed by the human eye, increasing the accuracy of screening and reducing the number of false-positive results.
- Advanced MRI and CT Scans: New imaging techniques, such as diffuse optical imaging, are being researched to provide more detailed, functional information about tissues. When combined with AI, these scans can help differentiate between benign and malignant tumors with greater precision.
- Digital Pathology: AI is transforming pathology by analyzing whole-slide images of biopsies. These platforms can quickly identify cancerous cells and patterns, reducing the workload on pathologists and improving diagnostic speed and consistency.